Skip to main content

Advertisement

Log in

Langerhans cell histiocytosis of the thyroid together with papillary thyroid carcinoma

  • Case Report
  • Published:
Hormones Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Ng-Cheng-Hin B, O’Hanlon-Brown C, Alifrangis C, Waxman J (2011) Langerhans cell histiocytosis: old disease new treatment. QJM 104(2):89–96

    Article  CAS  Google Scholar 

  2. Donadieu J, Chalard F, Jeziorski E (2012) Medical management of langerhans cell histiocytosis from diagnosis to treatment. Expert Opin Pharmacother 13(9):1309–1322

    Article  CAS  Google Scholar 

  3. Safali M, McCutcheon JM, Wright DH (1997) Langerhans cell histiocytosis of lymph nodes: draining a papillary carcinoma of the thyroid. Histopathology 30(6):599–603

    Article  CAS  Google Scholar 

  4. Patten DK, Wani Z, Tolley N (2012) Solitary langerhans histiocytosis of the thyroid gland: a case report and literature review. Head Neck Pathol 6(2):279–289

    Article  Google Scholar 

  5. Xia CX, Li R, Wang ZH, Lv FJ, Tang XQ, Li QF, Zhang SH (2012) A rare cause of goiter: Langerhans cell histiocytosis of the thyroid. Endocr J 59(1):47–54

    Article  Google Scholar 

  6. Goldstein N, Layfield LJ (1991) Thyromegaly secondary to simultaneous papillary carcinoma and histiocytosis X. Report of a case and review of the literature. Acta Cytol 35(4):422–426

    CAS  PubMed  Google Scholar 

  7. Thompson LD (1996) Langerhans cell histiocytosis isolated to the thyroid gland. Eur Arch Otorhinolaryngol 253(1–2):62–65

    CAS  PubMed  Google Scholar 

  8. Saiz E, Bakotic BW (2000) Isolated Langerhans cell histiocytosis of the thyroid: a report of two cases with nuclear imaging-pathologic correlation. Ann Diagn Pathol 4(1):23–28

    Article  CAS  Google Scholar 

  9. Foulet-Rogé A, Josselin N, Guyetant S, Gardet JJ, Besancon A, Saint-André JP, Fabiani B (2002) Incidental langerhans cell histiocytosis of thyroid: case report and review of the literature. Endocr Pathol 13(3):227–233

    Article  Google Scholar 

  10. Burnett A, Carney D, Mukhopadhyay S, Scalzetti EM, Leino D, Souid AK (2008) Thyroid involvement with Langerhans cell histiocytosis in a 3-year-old male. Pediatr Blood Cancer 50(3):726–727

    Article  Google Scholar 

  11. Jamaati HR, Shadmehr MB, Saidi B, Khosravi A, Arab M, Mohammadi F (2009) Langerhans cell histiocytosis of the lung and thyroid, co-existing with papillary thyroid cancer. Endocr Pathol 20(2):133–136

    Article  Google Scholar 

  12. Vergez S, Rouquette I, Ancey M, Serrano E, Caron P (2010) Langerhans cell histiocytosis of the thyroid is a rare entity, but an association with a papillary thyroid carcinoma is often described. Endocr Pathol 21(4):274–276

    Article  Google Scholar 

  13. Ceyran AB, Senol S, Bayraktar B, Ozkanlı S, Cinel ZL, Aydın A (2014) Langerhans cell histiocytosis of the thyroid with multiple cervical lymph node involvement accompanying metastatic thyroid papillary carcinoma. Case Rep Pathol 2014:184237

    PubMed  PubMed Central  Google Scholar 

  14. Gordon MS, Gordon MB (2016) Occult Langerhans cell histiocytosis presenting with papillary thyroid carcinoma, a thickened pituitary stalk and diabetes insipidus. Case Rep Endocrinol 2016:5191903

    PubMed  PubMed Central  Google Scholar 

  15. AlZahrani R, Algarni M, Alhakami H, AlSubayea H, Alfattani N, Guler M, Satti M (2016) Thyroid Langerhans cell histiocytosis and papillary thyroid carcinoma. Gland Surg 5(5):537–540

    Article  Google Scholar 

  16. Wu X, Chen S, Zhang LY, Luo YP, Jiang Y, Feng RE (2017) Langerhans cell histiocytosis of the thyroid complicated by papillary thyroid carcinoma: a case report and brief literature review. Medicine (Baltimore) 96(35):e7954

    Article  Google Scholar 

  17. Al Hamad AM, Albisher HM, Al Saeed WR, Almumtin AT, Allabbad FM, Shawarby AM (2019) BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review. BMC Cancer 19(1):170

    Article  Google Scholar 

  18. Moschovi M, Adamaki M, Vlahopoulos S, Rodriguez-Galindo C (2015) Synchronous and metachronous thyroid cancer in relation to Langerhans cell histiocytosis; involvement of V600E BRAF-mutation? Pediatr Blood Cancer 62(1):173–174

    Article  CAS  Google Scholar 

  19. Hershkovitch D, Avril MF, Bosq J, Caillou B, Nguyen T, Hayat M, Schlumberger M, Travagli JP, Desvignes V, Guillaume JC (1989) Generalized histiocytosis X in adults. Association with cancer of the thyroid. Ann Dermatol Venereol 116(11):875–878

    CAS  PubMed  Google Scholar 

  20. Dong Hae Chung SYH, Cho HY, Kim NR, An JS, Lee Y-D, Park S (2012) Langerhans cell histiocytosis in the thyroid and draining lymph nodes: a case report. Endocrinol Metab 27(2):138–141

    Article  Google Scholar 

  21. Abla O, Egeler RM, Weitzman S (2010) Langerhans cell histiocytosis: current concepts and treatments. Cancer Treat Rev 36(4):354–359

    Article  CAS  Google Scholar 

  22. Rizzo FM, Cives M, Simone V, Silvestris F (2014) New insights into the molecular pathogenesis of langerhans cell histiocytosis. Oncologist 19(2):151–163

    Article  CAS  Google Scholar 

  23. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D (2003) BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95(8):625–627

    Article  CAS  Google Scholar 

  24. Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM et al (2013) Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309(14):1493–1501

    Article  CAS  Google Scholar 

  25. Ascierto PA, Kirkwood JM, Grob JJ, Simeone E, Grimaldi AM, Maio M, Palmieri G, Testori A, Marincola FM, Mozzillo N (2012) The role of BRAF V600 mutation in melanoma. J Transl Med 10:85

    Article  CAS  Google Scholar 

  26. Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, Materazzi G, Elisei R, Santoro M, Miccoli P et al (2007) Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 92(11):4085–4090

    Article  CAS  Google Scholar 

  27. Kurtulmus N, Duren M, Ince U, Cengiz Yakicier M, Peker O, Aydın O, Altiok E, Giray S, Azizlerli H (2012) BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness. Endocrine 42(2):404–410

    Article  CAS  Google Scholar 

  28. Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G et al (2005) BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90(12):6373–6379

    Article  CAS  Google Scholar 

  29. Kim YS, Kim JS, Bae JS, Park WC (2013) Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma. World J Surg Oncol 11:99

    Article  Google Scholar 

  30. Gandolfi G, Sancisi V, Torricelli F, Ragazzi M, Frasoldati A, Piana S, Ciarrocchi A (2013) Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progression. J Clin Endocrinol Metab 98(5):E934–E942

    Article  Google Scholar 

  31. Dağlar-Aday A, Toptaş B, Oztürk T, Seyhan F, Saygili N, Eronat AP, Akadam-Teker B, Yilmaz-Aydoğan H, Aksoy F, Oztürk O (2013) Investigation of BRAF V600E mutation in papillary thyroid carcinoma and tumor-surrounding nontumoral tissues. DNA Cell Biol 32(1):13–18

    Article  Google Scholar 

  32. Kumar R, Angelini S, Snellman E, Hemminki K (2004) BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 122(2):342–348

    Article  CAS  Google Scholar 

  33. Makras P, Samara C, Antoniou M, Zetos A, Papadogias D, Nikolakopoulou Z, Andreakos E, Toloumis G, Kontogeorgos G, Piaditis G et al (2006) Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Neuroradiology 48(1):37–44

    Article  CAS  Google Scholar 

  34. Haupt R, Nanduri V, Calevo MG, Bernstrand C, Braier JL, Broadbent V, Rey G, McClain KL, Janka-Schaub G, Egeler RM (2004) Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 42(5):438–444

    Article  Google Scholar 

  35. Prosch H, Grois N, Prayer D, Waldhauser F, Steiner M, Minkov M, Gadner H (2004) Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatr Blood Cancer 43(5):594–599

    Article  Google Scholar 

  36. Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, Monson JP, Besser GM, Grossman AB (2000) Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 85(4):1370–1376

    Article  CAS  Google Scholar 

  37. Makras P, Piaditis G, Kaltsas GA (2007) Systemic and endocrine manifestations of Langerhans’ cell histiocytosis: current concepts in diagnosis and management. Expert Rev Endocrinol Metab 2(6):773–783

    Article  Google Scholar 

  38. Héritier S, Emile JF, Barkaoui MA, Thomas C, Fraitag S, Boudjemaa S, Renaud F, Moreau A, Peuchmaur M, Chassagne-Clément C et al (2016) BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy. J Clin Oncol 34(25):3023–3030

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hatice Ozisik.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

We had informed consent from patients.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ozisik, H., Yurekli, B.S., Demir, D. et al. Langerhans cell histiocytosis of the thyroid together with papillary thyroid carcinoma. Hormones 19, 253–259 (2020). https://doi.org/10.1007/s42000-020-00181-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42000-020-00181-2

Navigation